Family company is centre stage in American Revolution battle re-enactments
THE military expertise of Wyedean Weaving is 'front and centre' of international commemorations of the American Revolution.
Orders of the company's regimental lace have increased by nearly 20per cent as re-enactment groups across the UK create replica British regimental uniforms associated with the 250th anniversary of the American War of Independence.
Since January, the Haworth-based team has fulfilled re-enactment orders totalling 500 metres of regimental lace alone, in preparation for the 250th anniversary of the American Revolution. In addition to this, there has been a notable uplift in sales of other decorative trims such as herringbone twill design laces, flat braid, and worsted braided cord - all commonly used to adorn military uniforms for celebrations, re-enactments, and historic occasions.
Richard Marren and 7th Fusiliers on route from Boston to Lexington. Image: Richard Marren
Wyedean's Business Development Director Rosie Wright said that regimental lace is made on the company's site at Bridgehouse Mill with the family business holding 5,600 metres of lace across 70 distinctive designs, each woven with heritage in mind: 'The regimental laces are woven on traditional shuttle looms onsite in our Haworth Mill, and where required we can create new designs or tweak the old designs according to customer requirements.
'Over the last six months we have also dedicated one of our needle-looms to weaving these intricate laces due to the increase in orders.'
Wyedean worsted lace in production (Image: Richard Marren)
She added: 'As specialists in military uniform accoutrement, we have a rich history spanning 50 years of creating 128 unique designs, many of which have subtly evolved to reflect regimental changes over time.
'Every thread tells a story of tradition excellence and our commitment to quality and we are finding an increasing number of orders from UK and overseas re-enactment groups whose eye for detail and accuracy means they want the very best replica lace for their uniforms.'
Richard Marren in uniform with Susan Cately, a 'colonial citizen' at Battle Road. Image: Richard Marren
This April saw the anniversary of the 250th Battle of Lexington and Concord, which took place in April 1775 at the start of the American Revolution.
Taking part in commemorations of the Battle of Lexington and Concord is Cheshire-based Richard Marren who founded re-enactment group the 23rd Regiment of Foot, Royal Welch Fusiliers. Historically, each regiment has its own specific uniform design and Richard uses Wyedean's custom made regimental lace and Wyedean's plain white worsted (a type of wool yarn) for a sergeant's coat.
Armed with his Wyedean-accoutrement adorned uniforms, Richard travelled to Boston in April for the 250th anniversary of the Battle of Lexington and Concord - the first battle of the war in which the 23rd Foot fought.
Richard's uniform in progress
Richard said: 'It's critical that we research our uniforms from scratch and go for the highest quality. For this particular re-enactment, organisers can refuse you entry to an event if your uniform isn't authentic. To achieve this, we go thread to thread comparing today's recreations with examples from the past.
Richard Marren's 23rd 1770s coat with Wyedean lace (Image: Richard Marren)
'For this event, we worked with Wyedean to base our 23rd Regiment of Foot, Royal Welch Fusiliers military lace on the original sample held in the 1768 Lace Book at Windsor Castle.
'Wyedean were fantastic in ensuring the lace was a truly accurate representation of that used on the uniforms from the era and as a result the lace looks more striking than ever before and my uniform passed the reenactment authenticity standards - which is a real achievement.'
Richard joined that re-enactors from across the world to portray the 'redcoats' who fought at Lexington Green and 'Battle Road', the fight between Lexington Green and the town of Concord. Around 350 re-enactors portrayed the British Army and the event included a six-mile night-time march along the route taken by the regiment in 1775.
He said: 'Over the week we marched 18 miles in total and it was amazing to be part of what was almost a full-sized company, which is rare for a redcoat reenactment. It was so tough and everyone was exhausted by the end, but we all felt we owed it to the soldiers of the past to continue.'
Wyedean was founded as a manufacturer of braid and military uniform accoutrement in Haworth in 1964 by David Wright. In 2023, the family-run company secured the £5million, seven-year contract to replace British Armed Forces' Colours and Standards with the new King's insignia and the Tudor Crown.
Rosie added: 'While a high percentage of our time is spent on producing ceremonial military uniform accoutrement for armed and uniformed services at home and abroad, we're delighted to use our resources and expertise to recreate military wear from the past and help others in their retelling of important historical moments by facilitating the high quality uniform needs of reenactment groups across the country.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Washington Post
30 minutes ago
- Washington Post
Getty Images and Stability AI face off in British copyright trial that will test AI industry
LONDON — Getty Images is facing off against artificial intelligence company Stability AI in a London courtroom for the first major copyright trial of the generative AI industry. Opening arguments before a judge at the British High Court are scheduled for Monday. The trial could last for three weeks. Stability, based in London, owns a widely used AI image-making tool that sparked enthusiasm for the instant creation of AI artwork and photorealistic images upon its release in August 2022. OpenAI introduced its surprise hit chatbot ChatGPT three months later. Seattle-based Getty has argued that the development of the AI image maker, called Stable Diffusion, involved 'brazen infringement' of Getty's photography collection 'on a staggering scale.' Tech companies have long argued that 'fair use' or 'fair dealing' legal doctrines in the United States and United Kingdom allow them to train their AI systems on large troves of writings or images. Getty was among the first to challenge those practices when it filed copyright infringement lawsuits in the United States and the United Kingdom in early 2023. 'What Stability did was inappropriate,' Getty CEO Craig Peters told The Associated Press in 2023. He said creators of intellectual property should be asked for permission before their works are fed into AI systems rather than having to participate in an 'opt-out regime.' Stability has argued that the case doesn't belong in the United Kingdom because the training of the AI model technically happened elsewhere, on computers run by U.S. tech giant Amazon. Similar cases in the U.S. have not yet gone to trial. Stable Diffusion's roots trace to Germany, where computer scientists at Ludwig Maximilian University of Munich worked with the New York-based tech company Runway to develop the original algorithms. The university researchers credited Stability AI for providing the servers that trained the models, which require large amounts of computing power.


Business Wire
32 minutes ago
- Business Wire
Avanzanite Announces Pan-European Partnership with Agios to Launch PYRUKYND ® in Rare Blood Disorders
AMSTERDAM--(BUSINESS WIRE)--Avanzanite Bioscience B.V. ('Avanzanite'), a fast-growing commercial-stage specialty pharmaceutical company dedicated to bringing rare disease medicines to patients across Europe, announced today an exclusive agreement with Agios Pharmaceuticals Inc. (Nasdaq: AGIO), a Boston-based biotech company focused on the development and commercialization of rare disease medicines. Under the agreement, Avanzanite will commercialize and distribute PYRUKYND® (mitapivat) across the European Economic Area, the UK and Switzerland. 'This partnership marks a major milestone in our mission to transform how rare disease therapies reach patients in Europe' Share 'This partnership marks a major milestone in our mission to transform how rare disease therapies reach patients in Europe,' said Adam Plich, Founder and CEO of Avanzanite. 'We provide biotech partners with a capital-efficient path to sustainable patient access – without the burden of building a costly local infrastructure. We look forward to working with Agios to help bring PYRUKYND® to patients across Europe, further advancing our efforts to set a new benchmark for biotech commercial and distribution partnerships in the region. This is just the beginning.' PYRUKYND®, a first-in-class, oral, pyruvate kinase (PK) activator, is approved by the European Commission and the UK's Medicines and Healthcare products Regulatory Agency for the treatment of adult patients with PK deficiency. PK deficiency is an ultra-rare, inherited condition that causes premature red blood cell breakdown, leading to chronic anemia, serious complications, and reduced quality of life. Until recently, there were no approved treatments. Agios also has a robust mid- and late-stage pipeline, with clinical programs focused on other rare diseases, including thalassemia and sickle cell disease. The partnership also includes potential future indications. Avanzanite is rapidly scaling its operations, having tripled its revenue in Q1 2025 year-over-year, with two rare disease medicines already on the market. Over the next 12 months, the company will expand into 32 European countries, including new territories of Italy, France, the UK, Romania, and Spain. 'Avanzanite goes truly pan-European,' concluded Plich. 'And as we expand across the continent, our promise stays the same – making sure no patient is left behind.' About Avanzanite Avanzanite is redefining launches of rare disease medicines across Europe. Founded in 2022 and based in Amsterdam, the company partners with biotech innovators to unlock the full commercial value of orphan medicines continent-wide. With our deep expertise in market access, we navigate Europe's complex landscape like master chess players – ensuring no patient is left behind. Learn more at


Bloomberg
34 minutes ago
- Bloomberg
BP Takeover Would Be a Longshot Due to Size and Complexity, Moelis Bankers Say
The chances that a rival oil company will take over BP Plc are slim right now, even as peers have been running the numbers, because of the firm's size and complexity, said bankers from Moelis & Co. 'We can't identify anybody in the US that would be a buyer,' Moelis Chairman and Global Head of Energy and Clean Technology Stephen Trauber said in an interview in London on Monday. 'We don't really see any others globally that are buyers that view the assets as must-have.'